...will supply Roche with active pharmaceutical ingredients. The deal is expected to close this quarter. International Chemical Investors Group...

...technologies portion, for an undisclosed sum (see BioCentury, Feb. 7). Genzyme Corp. (NADAQ:GENZ), Cambridge, Mass. International Chemical Investors Group...

...cash (see BioCentury, May 10, 2010 & Dec. 6, 2010). Genzyme Corp. (NASDAQ:GENZ), Cambridge, Mass. International Chemical Investors Group...

...1.1 million (0.4%) of Genzyme shares to sanofi. Also last week, Genzyme said that the International Chemical Investors Group...

...The facilities, are located in Ireland and Belgium, respectively. Cambrex Corp. (CBM), East Rutherford, N.J. International Chemical Investors Group...

...sell two manufacturing facilities within its human health business to a holding company controlled by International Chemical Investors...